Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven A Pergam

Showing results (101-110 of 134) with videos related to

Pageof 14
Sort By:
Transplantation and Cellular Therapy|August 23, 2024
COVID-19 Outcomes Among Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-Cell Recipients in the Era of SARS-CoV-2 Omicron Variants and COVID-19 TherapeuticsEmily A Rosen, Elizabeth M Krantz, Denise J McCulloch, et al.
Infection Control and Hospital Epidemiology|June 5, 2024
Society for Healthcare Epidemiology of America position statement on pandemic preparedness for policymakers: mitigating supply shortagesDavid Jay Weber, Anurag N Malani, Erica S Shenoy, et al.
Infection Control and Hospital Epidemiology|June 5, 2024
SHEA position statement on pandemic preparedness for policymakers: building a strong and resilient healthcare workforceDavid B Banach, Trini A Mathew, Lynne Jones Batshon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 13, 2017
Graft-Derived Reconstitution of Mucosal-Associated Invariant T Cells after Allogeneic Hematopoietic Cell TransplantationAbir Bhattacharyya, Laïla-Aïcha Hanafi, Alyssa Sheih, et al.
Transplantation and Cellular Therapy|October 23, 2022
Frequently Asked Questions on Coronavirus Disease 2019 Vaccination for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Recipients From the American Society for Transplantation and Cellular Therapy and the American Society of HematologyFareed Khawaja, Genovefa Papanicolaou, Sanjeet Dadwal, et al.
Infection Control and Hospital Epidemiology|July 19, 2024
SHEA position statement on pandemic preparedness for policymakers: emerging infectious threatsVincent P Hsu, Steven A Pergam, Erica S Shenoy, et al.
Infection Control and Hospital Epidemiology|June 5, 2024
SHEA position statement on pandemic preparedness for policymakers: introduction and overviewVincent P Hsu, Sarah Haessler, David B Banach, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 10, 2020
High Incidence of Herpes Zoster After Cord Blood Hematopoietic Cell Transplant Despite Longer Duration of Antiviral ProphylaxisElisabetta Xue, Hu Xie, Wendy M Leisenring, et al.
The Journal of Infectious Diseases|August 3, 2013
Safety and immunogenicity of heat-treated zoster vaccine (ZVHT) in immunocompromised adultsKathleen M Mullane, Drew J Winston, Michael S Wertheim, et al.
Infection Control and Hospital Epidemiology|June 5, 2024
SHEA position statement on pandemic preparedness for policymakers: pandemic data collection, maintenance, and releaseWestyn Branch-Elliman, David B Banach, Lynne J Batshon, et al.
Pageof 14

Showing results (101-110 of 134) with videos related to

Sort By:
Pageof 14
Transplantation and Cellular Therapy|August 23, 2024
COVID-19 Outcomes Among Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-Cell Recipients in the Era of SARS-CoV-2 Omicron Variants and COVID-19 TherapeuticsEmily A Rosen, Elizabeth M Krantz, Denise J McCulloch, et al.
Infection Control and Hospital Epidemiology|June 5, 2024
Society for Healthcare Epidemiology of America position statement on pandemic preparedness for policymakers: mitigating supply shortagesDavid Jay Weber, Anurag N Malani, Erica S Shenoy, et al.
Infection Control and Hospital Epidemiology|June 5, 2024
SHEA position statement on pandemic preparedness for policymakers: building a strong and resilient healthcare workforceDavid B Banach, Trini A Mathew, Lynne Jones Batshon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 13, 2017
Graft-Derived Reconstitution of Mucosal-Associated Invariant T Cells after Allogeneic Hematopoietic Cell TransplantationAbir Bhattacharyya, Laïla-Aïcha Hanafi, Alyssa Sheih, et al.
Transplantation and Cellular Therapy|October 23, 2022
Frequently Asked Questions on Coronavirus Disease 2019 Vaccination for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Recipients From the American Society for Transplantation and Cellular Therapy and the American Society of HematologyFareed Khawaja, Genovefa Papanicolaou, Sanjeet Dadwal, et al.
Infection Control and Hospital Epidemiology|July 19, 2024
SHEA position statement on pandemic preparedness for policymakers: emerging infectious threatsVincent P Hsu, Steven A Pergam, Erica S Shenoy, et al.
Infection Control and Hospital Epidemiology|June 5, 2024
SHEA position statement on pandemic preparedness for policymakers: introduction and overviewVincent P Hsu, Sarah Haessler, David B Banach, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 10, 2020
High Incidence of Herpes Zoster After Cord Blood Hematopoietic Cell Transplant Despite Longer Duration of Antiviral ProphylaxisElisabetta Xue, Hu Xie, Wendy M Leisenring, et al.
The Journal of Infectious Diseases|August 3, 2013
Safety and immunogenicity of heat-treated zoster vaccine (ZVHT) in immunocompromised adultsKathleen M Mullane, Drew J Winston, Michael S Wertheim, et al.
Infection Control and Hospital Epidemiology|June 5, 2024
SHEA position statement on pandemic preparedness for policymakers: pandemic data collection, maintenance, and releaseWestyn Branch-Elliman, David B Banach, Lynne J Batshon, et al.
Pageof 14